
In recent years no cancer therapeutic class has undergone more prolific or successful drug development efforts than the zzso zzso The robust research interest is evident in the number of zzso inhibitor presentations at the American Association for Cancer Research Annual Meeting held in Denver zzso zzso zzso April zzso zzso highlights from the zzso zzso 4 zzso include the identification of zzso zzso genetic zzso that correlate with sensitivity to the zzso inhibitor zzso evaluation of activity of zzso zzso zzso zzso and zzso in breast and zzso lung cancer and the identification of new zzso to zzso zzso 

